Serum homocysteine level in patients with ankylosing spondylitis

Rheumatology International

Volumn 29, Issue 12, 2009, Pages 1435-1439

  Başkan, Bedriye Mermerci ^a   Sivas, Filiz ^a   Aktekin, Lale Akbulut ^a   Doğan, Yasemin Pekin ^a   Özoran, Kürşat ^a   Bodur, Hatice ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Ankylosing spondylitis; Disease activity parameters; Homocysteine level

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID; HOMOCYSTEINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 69049089742     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0875-x     Document Type: Article

References (31)

1. JW Eikelboom E Lonn J Genest Jr, et al. 1999 Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence Ann Intern Med 131 363 375
2. CJ Boushey SA Beresford GS Omenn, et al. 1995 A quantative assessment of plasma homocysteine as a risk factor for vascular disease JAMA 274 13 1049 1057
3. PH Whincup H Refsum IJ Perry, et al. 1999 Serum total homocysteine and coronary heart disease: prospective study in middle aged men Heart 82 448 454
4. O Nygard SE Vollset H Refsum, et al. 1995 Total plazma homocysteine and cardiovascular risk profile JAMA 274 19 1526 1533
5. Gonçalves M, D'Almeida V, Guerra-Shinohara EM et al. (2007) Homocysteine and lipid profile in children with juvenile idiopathic arthritis. Pediatr Rheumatol. doi: 10.1186/1546-0096-5-2
6. Rveille J (2008) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 4th edn. Elsevier, Spain, pp 1109-1114
7. H Divecha N Sattar A Rumley, et al. 2005 Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation Clin Sci 109 2 171 176
8. J Sieper J Braun M Rudwaleit, et al. 2002 Ankylosing spondylitis: an overview Ann Rheum Dis 61 Suppl 3 iii8 iii18
9. N Hornung T Ellingsen K Stengard Pedersen, et al. 2004 Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and effect of low dose folic acid supplement J Rheumatol 31 12 2374 2381
10. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 4 361 368
11. S Garret T Jenksion L Kennedy, et al. 1994 A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 21 2286 2291
12. A Calin S Garret HC Whitelock, et al. 1994 A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index J Rheumatol 21 12 2281 2285
13. Y Akkoç AG Karatepe S Akar, et al. 2005 The Turkish versions of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity Rheumatol Int 25 4 280 284
14. B YanIk Y Kurtaiş Gürsel Ş Kutlay, et al. 2005 Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Türkish population, its reliability and validity: functional assessment in AS Clin Rheumatol 24 41 47
15. SL Morgan JE Baggott JY Lee, et al. 1998 Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention J Rheumatol 25 3 441 446
16. JC Wei MS Jan CT Yu, et al. 2007 Plasma homocysteine status in patients with ankylosing spondylitis Clin Rheumatol 26 739 742
17. MM Chilvers P Wordsworth A Stubbs, et al. 1998 TCR usage by homocysteine-specific human CTL J Immunol 160 8 3737 3742
18. XM Gao P Wordsworth AJ McMichael, et al. 1996 Homocysteine modification of HLA antigens and its immunological consequences Eur J Immunol 26 1443 1450
19. R Roubenoff P Dellaripa MR Nadeau, et al. 1997 Abnormal homocysteine metabolism in rheumatoid arthritis Arthritis Rheum 40 4 718 722
20. CJ Haagsma HJ Blom PL van Riel, et al. 1999 Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann Rheum Dis 58 2 79 84
21. D Malesci A Niglio GA Mennillo, et al. 2007 High prevalence of metabolic syndrome in patients with ankylosing spondylitis Clin Rheumatol 26 5 710 714
22. L Gonzalez-Lopez JD Sancez-Hernandez EA Aguilar Chavez, et al. 2008 Hyperhomocysteinemi in ankylosing spondylitis: prevalence and association with clinical variables Rheumatol Int 28 12 1223 1228
23. EH Broxson LC Stork RH Allen, et al. 1989 Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions Cancer Res 49 21 5879 5883
24. G Jansen J van der Heijden R Oerlemans, et al. 2004 Sulfasalazine is a potent inhibitor of the reduced folat carrier: implications for combination therapies with methotrexate in rheumatoid arthritis Arthritis Rheum 50 7 2130 2139
25. J Zimmerman 1992 Drug interactions in intestinal transport of folic acid and methotrexate Biochem Pharmacol 44 1839 1842
26. J Selhub GJ Dhar IH Rosenberg 1978 Inhibition of folat enzyms by sulfasalazine J Clin Invest 61 221 224
27. JE Baggott SL Morgan T Ha, et al. 1992 Inhibition of folat-dependent enzyms by non-steroidal anti-inflammatory drugs Biochem J 282 197 202
28. OK Jensen C Rasmussen F Mollerup, et al. 2002 Hyper homocysteinemi in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation J Rheumatol 29 8 1615 1618
29. MA Lopez-Olivo L Gonzalez-Lopez A Garcia-Gonzalez, et al. 2006 Factors associated with hyperhomocysteinaemi in Mexican patients with rheumatoid arthritis Scand J Rheumatol 35 2 112 116
30. MJ Peters IE van der Horst-Bruinsma BA Dijkmans, et al. 2004 Cardiovascular risk profile of patients with spondyloarthropaties, particularly ankylosing spondylitis and psoriatic arthritis Semin Arthritis Rheum 34 3 585 592
31. K Lehtinen 1993 Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis Ann Rheum Dis 52 174 176